Soliris
Soliris works by selectively inhibiting activation of specific proteins in the complement system (C5a and C5b), which play a role in the pathophysiology of multiple rare diseases.
Archive for Myasthenia Gravis (MG)
Vyvgart
Vyvgart (efgartigimod alfa-fcab) is a prescription medication used for the treatment of generalized myasthenia gravis in adults who are positive for antibodies directed toward a protein called the acetylcholine receptor (anti-AChR antibody positive).
Ultomoris
Ultomiris is a medication used for the treatment of generalized myasthenia gravis
(gMG) in adult patients who are anti-acetylcholine receptor (AchR) antibody positive as
well as those with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic
uremic syndrome (aHUS).
Rystiggo
Rystiggo is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients.
Vyvgart Hytrulo
VYVGART HYTRULO is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive and for patients with chronic inflammatory demyelinating polyneuropathy (CIDP).